跳至主要内容
临床试验/CTRI/2025/08/092979
CTRI/2025/08/092979尚未招募Phase 3 4

A study on the effectiveness of Individualised Homoeopathic medicine in treating of Generalised Anxiety Disorder assessed using Hamilton anxiety scale

Post graduate research funded by sarda Krishna homoeopathic medical college1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2025年8月30日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
28
试验地点
1
主要终点
The Primary outcome measure will be the change in scores on the Hamilton Anxiety Rating scale

研究概览

简要总结

Generalised anxiety disorder (GAD) is a mental and behavioural disorder. Which is characterised by excessive anxiety and worry, which is very difficult to control together with impaired physical, social, occupational or other areas of functioning. Persons with generalised anxiety disorder are anxious and worried about almost everything in their life  There is a need to identify and treat generalised anxiety disorder patients in order to cause significant distress or impairment in personal, family, social, educational, occupational, or other important areas of functioning The interventions used will vary for every patient as we are administering individualized homeopathic medicine in generalized anxiety disorder to improve outcomes and a better quality of life for those disorders. PROCEDURE  Medicine will be based on totality of symptom  Patient will be followed up at regular interval (monthly) for a specific duration to monitor treatment progress and assess outcome measures The patient is assessed with HAMILTON ANXIETY RATING SCALE for knowing the severity of generalized anxiety disorder before homeopathic intervention. OUTCOME The primary outcome measure will be the change in scores on the Hamilton Anxiety Rating scale (HAM-A) from baseline to the end of the study. Assessment is done every month of medications and the case is followed up to a period of 1 year.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
19.00 Year(s) 至 64.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with generalised anxiety disorder according to ICD 10 criteria.

排除标准

  • Patients with comorbid psychiatric disorders requiring immediate attention (e.g., psychosis, severe depression, bipolar disorder) Patients with a history of substance abuse Those unable to understand or comply with the study procedures.

结局指标

主要结局

The Primary outcome measure will be the change in scores on the Hamilton Anxiety Rating scale

时间窗: 1 year

次要结局

  • The change in scores on the Hamilton Anxiety Rating scale from baseline to the end of the study. Assessment is done every month of medications and the case is followed up to a period of 1 year(1 year)

研究者

发起方
Post graduate research funded by sarda Krishna homoeopathic medical college
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Ajitha I

Sarada Krishna Homoeopathic Medical College

研究点 (1)

Loading locations...

相似试验